ALT > 3-fold ULN significantly increased after 2 weeks in 3.2% at 280 mg BID,with 2 cases of symptomatic hepatitis with ALT rises ≥ 10-fold. ALT rises generallyoccurred while on drug and resolved rapidly on discontinuation. Discontinued inphase 3. This evidence concerns the gene GPT and hepatitis A virus infection.